Drug Profile
MP4CO
Alternative Names: Carbon monoxide-carrying colloid - Sangart; Carbon monoxide-carrying pegylated haemoglobin - Sangart; PEG carboxyhaemoglobin; Pegylated carboxyhaemoglobinLatest Information Update: 27 Nov 2019
Price :
$50
*
At a glance
- Originator Sangart
- Class Anti-ischaemics; Haemoglobins; Polyethylene glycols
- Mechanism of Action Haemoglobin modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Vaso-occlusive crisis
Most Recent Events
- 19 Nov 2013 No development reported - Phase-I for Vaso-occlusive crisis related to sickle cell anaemia in Lebanon, Jamaica, France, United Kingdom (IV)
- 16 Aug 2013 Sangart plans a phase II trial for Vaso-occlusive crisis related to sickle cell anaemia in United Kingdom, France, Belgium, Netherlands, Turkey, Brazil, Bahrain, Lebanon & Qatar (NCT01925001)
- 31 Dec 2012 Sangart completes a phase I trial in Vaso-occlusive crisis related to sickle cell anaemia in United Kingdom, France, Jamaica & Lebanon (NCT01356485)